15-Deoxy-Δ12,14-prostaglandin J2-induced apoptosis does not require PPARγ in breast cancer cells
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 43 (11), 1818-1828
- https://doi.org/10.1194/jlr.m200224-jlr200
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor γ Inhibits Transforming Growth Factor β-induced Connective Tissue Growth Factor Expression in Human Aortic Smooth Muscle Cells by Interfering with Smad3Journal of Biological Chemistry, 2001
- Lessons from the glitazones: a story of drug developmentThe Lancet, 2001
- The Novel Triterpenoid CDDO Induces Apoptosis and Differentiation of Human Osteosarcoma Cells by a Caspase-8 Dependent MechanismMolecular Pharmacology, 2001
- Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient miceJournal of Clinical Investigation, 2000
- 15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cellsProstaglandins & Other Lipid Mediators, 2000
- Roles of PPARs in health and diseaseNature, 2000
- A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.Diabetes, 1999
- Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcomaProceedings of the National Academy of Sciences, 1999
- Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.Diabetes, 1999
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995